Panagora Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $581K | Buy |
+794,329
| New | +$581K | ﹤0.01% | 763 |
|
|
2022
Q2 | – | Sell |
-188,094
| Closed | -$2.43M | – | 1489 |
|
|
2022
Q1 | $2.43M | Buy |
188,094
+9,346
| +5% | +$121K | 0.01% | 629 |
|
|
2021
Q4 | $2.85M | Buy |
+178,748
| New | +$2.85M | 0.02% | 539 |
|
|
2021
Q3 | – | Sell |
-110
| Closed | -$2K | – | 1836 |
|
|
2021
Q2 | $2K | Sell |
110
-2,995
| -96% | -$54.5K | ﹤0.01% | 2622 |
|
|
2021
Q1 | $45K | Hold |
3,105
| – | – | ﹤0.01% | 2199 |
|
|
2020
Q4 | $54K | Hold |
3,105
| – | – | ﹤0.01% | 2026 |
|
|
2020
Q3 | $57K | Hold |
3,105
| – | – | ﹤0.01% | 1985 |
|
|
2020
Q2 | $55K | Sell |
3,105
-28,277
| -90% | -$501K | ﹤0.01% | 1952 |
|
|
2020
Q1 | $509K | Sell |
31,382
-209,989
| -87% | -$3.41M | ﹤0.01% | 1108 |
|
|
2019
Q4 | $4.35M | Buy |
241,371
+213,757
| +774% | +$3.85M | 0.02% | 527 |
|
|
2019
Q3 | $559K | Buy |
+27,614
| New | +$559K | ﹤0.01% | 1246 |
|
|
2017
Q1 | – | Sell |
-52,138
| Closed | -$1.47M | – | 2385 |
|
|
2016
Q4 | $1.47M | Buy |
+52,138
| New | +$1.47M | 0.01% | 1036 |
|
|
2016
Q1 | – | Sell |
-827
| Closed | -$19K | – | 2298 |
|
|
2015
Q4 | $19K | Sell |
827
-1,454
| -64% | -$33.4K | ﹤0.01% | 2149 |
|
|
2015
Q3 | $46K | Buy |
2,281
+1,610
| +240% | +$32.5K | ﹤0.01% | 2010 |
|
|
2015
Q2 | $19K | Sell |
671
-53,010
| -99% | -$1.5M | ﹤0.01% | 2313 |
|
|
2015
Q1 | $1.64M | Buy |
53,681
+24,566
| +84% | +$751K | 0.01% | 858 |
|
|
2014
Q4 | $475K | Buy |
+29,115
| New | +$475K | ﹤0.01% | 1304 |
|